Ocuphire Pharma Results

Measuring the Severity of Diabetic Retinopathy DRSS is Regularly Used For FDA Approvals; Not As Widely Used in Everyday Practice Ocuphire PHARMA Diabetic Retinopathy Severity Scale (DRSS) was developed to differentiate proliferative DR (PDR) from non-proliferative DR (NPDR) 10, 12 DR Absent 60, 61 Mild PDR 1 7 14, 15, 20 DR Questionable 65 Moderate PDR 2 8 35 Mild NPDR 71 High-risk PDR 3 43 Moderate NPDR 75 High-risk PDR 10 47 Moderately Severe NPDR 81 Advanced PDR 5 11 53 Severe NPDR 85 Advanced PDR Arcadu, F., Benmansour, F., Maunz, A. et al. Deep learning algorithm predicts diabetic retinopathy progression in individual patients. npj Digit. Med. 2, 92 (2019). https://doi.org/10.1038/s41746-019-0172-3. 12 14

View entire presentation